Novel Biotherapeutics To Modulate The Human Microbiome
What Makes Us Different
Transformative Research
We are trailblazers in the identification of beneficial microbes that play a crucial role in fighting infectious diseases, regulating the immune system, and boosting immunity. Our extensive expertise in understanding the human microbiome has allowed us to identify key bacteria that promote health and wellbeing. With our cutting-edge discovery pipeline, we can effectively characterize and quantify the microbiome in both healthy and diseased states, enabling us to make significant strides in disease prevention and treatment.
Bacteriocin-Producing Probiotics
Our innovative discovery platform empowers the identification of bacteria possessing drug-like properties and the production of a new class of antibiotic-like molecules (bacteriocins). Our research has led us to identify probiotic bacteria that produce Salivaricin 10, the world first phosphorylated lantibiotic, offering optimal therapeutic activity against oral and respiratory tract infections. We are proud to be pioneers in the field of microbiome therapies, providing a glimpse into the future of healthcare.
Primary Intellectual Property
Our patents provide extensive coverage for bacterial biotherapeutic drugs that utilize phosphorylated lantibiotics produced by beneficial microbes with dual antimicrobial/immunomodulation bioactivities offering promising therapeutic possibilities.
